Pharmaceutical industry – Page 18
-
Opinion
Embracing structural disorder
Medicinal chemists need to overcome their fear of fuzzy proteins
-
Business
Industry delves into the digital toolbox
Chemical companies are making their plants and processes increasingly digital, data-driven and interconnected
-
Business
Landmark ruling in Oklahoma opioid lawsuit
J&J judged responsible for ‘public nuisance’ in first case to go to trial
-
Article
RSSL experts on the science behind food and pharma
Three scientists, whose contributions help world-leading brands and SMEs develop and supply innovative, safe products, share their experiences working in the labs of contract research company Reading Scientific Services Limited (RSSL)
-
Podcast
Boric acid
Mike Freemantle revisits battlefield surgery to investigate boric acid, a key part of Dakin's antiseptic solution used extensively in the first world war
-
Research
Retrosynthetic algorithm broadened to design similar, but different, molecules
Chematica can now design efficient syntheses for large compound libraries
-
Podcast
Amygdalin & Laetrile
Patrick Hughes delves into the molecule at the centre of a decades-old cancer treatment conspiracy theory
-
Opinion
Will Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
News
Data manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
Opinion
Has x-ray had its day?
Will the giant of structure determination be toppled by blasts from electron beams?
-
Article
Accurate temperature control achieving big results, on a small scale
Radleys’ compact reaction station brings accurate temperature control to chemical scientists managing small-scale experiments
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Business
Enhancing solvents' sustainability
Increased recycling and replacing toxic solvents with greener alternatives will reduce environmental impact
-
Business
Pfizer’s Upjohn to merge with Mylan
Deal combines Pfizer’s off-patent drug portfolio with Mylan’s generics
-
-
Article
Multidisciplinary science kick starts innovation
Nanoform scientists discuss how their diverse personalities and scientific backgrounds foster innovation, helping them tackle problems from different angles, and design better processes
-
Opinion
The silent rise of the robots
Mechanical helpers have been creeping into our labs for decades
-
Business
Profile: Oxford nanoSystems’ heat transfer coatings
Nanospiked coatings drastically increase heat exchangers’ efficiency and can be applied after manufacturing
-
Opinion
Get with the quantum program
Now is the time for industry to engage with the emerging world of quantum computers
-
Business
AbbVie to acquire Allergan in multibillion-dollar merger
Takeover deal will create world’s fifth-largest pharma company